Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Opioid receptor antagonist reducing opioid induced respiratory depression More
AS-22 is a hypertonic, non-specific MMP-inhibiting, hydrating & cleaning solution to treat bedsores, diabetic ulcers, and venous leg ulcers. Reduces pain and promotes fast healing, even in case of refractory wounds More
Our gelatin is well established in the UK hospital martket More
Isoplex 4% w/v Solution for Infusion is well established in the UK market and this product may be available for suitable partners to license for registering and marketing in other territories. More
Collagen-based biodegradable matrices for localized drug delivery More
Related Reports
Market Research Reports provided by reports.iptechex.com
Jun 2006 - 952 pages - $2,495
Aug 2011 - 7 pages - $75
Aug 2011 - 7 pages - $75
Nov 2011 - 7 pages - $75
Sep 2007 - 18 pages - $1,695
Jan 2009 - 14 pages - $1,695
Dec 2009 - 10 pages - $1,695
May 2011 - 15 pages - $250
May 2011 - 15 pages - $125
Oct 2010 - 72 pages - $3,500
Your selection
Browse By
- Industry sector
- Generics
- Nutrition
- OTC/Non-Prescription
- Pediatric
- Personal Care
- Prescription
- Therapeutic target
- Accident & Trauma (other)
- Back Pain
- Bone fractures
- Burns
- CNS trauma
- Drug overdose
- Hemorraghic trauma
- Muscle sprain/strain
- Poisioning
- Reperfusion injury (lung/heart)
- Stroke/traumatic brain injury
- Tissue grafting
- Wound closure/surgical adhesive
- Wound/ulcer healing
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us